Histopathological Spectrum of Oral Leukoplakia and Its Malignant Trans formation Risk
DOI:
https://doi.org/10.48165/ajm.2026.9.01.39Keywords:
Oral Leukoplakia, Epithelial Dysplasia, Malignant Transformation, Oral Potentially Malignant Disorders, Histopathology, Oral Squamous Cell Carcinoma, Tobacco-related Lesions, Precancerous LesionsAbstract
Background:Oral leukoplakia is one of the most common potentially malignant oral disorders, with a variable risk of transformation into oral squamous cell carcinoma. Histopathological evaluation plays a vital role in assessing the severity of epithelial dysplasia and predicting malignant potential. Aim:To evaluate the histopathological spectrum of oral leukoplakia and assess its risk of malignant transformation based on clinicopathological findings. Materials and Methods:The present retrospective observational study included 60 histopathologically confirmed cases of oral leukoplakia. Clinical details, including age, gender, lesion site, clinical appearance, and associated habits, were collected from patient records. Histopathological examination was performed on hematoxylin- and eosin-stained sections, and lesions were categorised by the degree of epithelial dysplasia. The correlation between clinical presentation and the risk of malignant transformation was analysed. Results:The majority of cases were observed among males aged 41–60. Buccal mucosa was the most commonly affected site. Homogeneous leukoplakia was more prevalent; however, non-homogeneous lesions were more strongly associated with moderate and severe dysplasia. Histopathological analysis revealed mild epithelial dysplasia as the most common finding, whereas severe dysplasia and carcinoma in situ were associated with an increased risk of malignant transformation. Conclusion:The study highlights that oral leukoplakia exhibits a broad histopathological spectrum with variable malignant potential. Non-homogeneous lesions and higher grades of epithelial dysplasia were strongly associated with increased risk of malignant transformation. Therefore, early diagnosis, histopathological assessment, habit cessation, and long-term follow-up are essential for the prevention of progression to oral cancer. Advancement of Knowledge:The present study provides a detailed evaluation of the histopathological spectrum of oral leukoplakia and its association with the risk of malignant transformation. The study emphasises the importance of correlating clinical presentation with histopathological grading to enable early identification of high-risk lesions. It further highlights the significance of non-homogeneous leukoplakia and advanced epithelial dysplasia as important predictors of malignant progression. The findings contribute to a better understanding of disease behaviour and support the need for regular monitoring and timely intervention in patients with oral leukoplakia.
References
Andrea Rubert, J Clin Exp Dent. 2020 Jun 1;12(6):e540–e546, PMID: 32665812
Isaäc van der Waal, Med Oral Patol Oral Cir Bucal 2014 Jul 1;19(4):e386-90., PMID: 24905952
van der Waal I.Oral Oncol. 2010 Jun;46(6):423-5.Epub 2010 Mar 21.PMID: 20308005
Reibel J, .Ugeskr Laeger. 2010 Nov 1;172(44):3040-2. PMID: 21044562
Warnakulasuriya S, .J Oral Pathol Med. 2011 Oct;40(9):677-83. Epub 2011 Jul 18.PMID: 21762430
Thomson PJ,.J Oral Pathol Med. 2018 Jul;47(6):557-565. Epub 2018 Apr 29.PMID: 29663518
Nigam K.Med Oncol. 2021 Oct 11;38(12):139. .PMID: 34633549 Porter S.Br Dent J. 2014 Dec;217(12):660-1. PMID: 25524996 Zhang M.Oncol Lett. 2015 Sep;10(3):1841-1847. Epub 2015 Jun 25.PMID: 26622762
Elisabeth-R E A Brouns, Med Oral Patol Oral Cir Bucal. 2013 Jan 1;18(1):e19-26. PMID: 23085711
Brouns E.Oral Dis. 2014 Apr;20(3):e19-24. Epub 2013 Mar 25.PMID: 23521625
Sun Yat-sen Zhonghua Kou Qiang Yi Xue Za Zhi. 2001 Sep;36(5):364-6.PMID: 11769652
Bokor-Bratić M.Med Pregl. 2004 Jan-Feb;57(1-2):41-3. PMID: 15327189
Parlatescu I.Maedica (Bucur). 2014 Mar;9(1):88-93. PMID: 25553134
Gandara-Vila P, .Med Oral Patol Oral Cir Bucal. 2018 Jul 1;23(4):e413-e420.PMID: 2992475
Rubert A J Clin Exp Dent. 2021 May 1;13(5):e426-e432. PMID: 33981388
Čēma I,.Cancers (Basel). 2021 Nov 16;13(22):5739. PMID: 34830890
Stefano Petti, Oral Oncol 2003 Dec;39(8):770-80. PMID: 13679200 Downer MC.Evid Based Dent. 2005;6(1):12; author reply .PMID: 15789044
Chaturvedi AK, J Natl Cancer Inst. 2020 Oct 1;112(10):1047-1054. PMID: 31860085

